WHITNEY LYON: Open Payments
NPI 1780124065 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 10 payments from 6 companies in 2025. Trend: 2023 $667 · 2024 $563 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| ABBVIE INC. | 3 | $67 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, UZEDY, LOREEV XR, LYBALVI, Qelbree.
Industry payments across IN — which companies pay providers there.
